There appears to be limited evidence supporting the use of epidural steroid injections for certain types of chronic lower ...

DEAR DR. ROACH: I have suffered from chronic low back pain that affects my knees. I have seen at least six physical ...

In spinal stenosis, the injections appeared to reduce disability but not pain. Compared to those who didn’t receive ...

Epidural steroid injections may modestly reduce pain and disability for certain chronic back pain conditions, but their ...

The American Academy of Neurology (AAN) has developed a new systematic review to summarize for neurologists and other ...

Epidural steroid injections demonstrated limited efficacy in reducing back pain and disability, according to a systematic ...

"Sinus passages can become inflamed from an infection or allergies leading to the trapping air, fluid, and mucus inside — this creates pressure that leads to pain in the forehead, cheeks ...

A recent systematic review of the impact of LBP-related leg pain on outcomes concluded that leg pain appears to be associated with worse outcomes, but highlighted the lack of evidence concerning ...

The FDA's sign-off on the medication comes as the agency says it is prioritizing supporting the development of non-opioid pain treatment. Suzetrigine is the first non-opioid analgesic – or ...

The FDA has approved Vertex Pharmaceuticals’ oral Journavx (suzetrigine) to treat adults with moderate-to-severe acute pain.

Vertex is studying suzetrigine in sciatica; in a phase II trial, the drug showed a statistically significant change in lumbosacral radiculopathy pain from baseline, similar to the reduction in the ...